Black light does more than make posters glow. Cornell researchers have developed a chemical tool to control inflammation that is activated by ultraviolet (UV) light.
The method will allow scientists to study inflammation and the immune system, and may one day prove effective as a targeted therapy for inflammatory diseases, while minimizing side effects to healthy tissues.
The researchers, who reported their results in a study published in October in the journal Chemical Science, designed a small molecule that is capable of controlling an immune response when exposed to UV light radiation.
“Currently, there aren’t a lot of tools that are able to manipulate the immune system in a spatio-temporal fashion,” said Pamela Chang, assistant professor of microbiology and immunology, and the paper’s senior author. Bibudha Parasar, a graduate student in Chang’s lab, is the paper’s first author.
“We are pushing the forefront of developing new technologies to control inflammation and the immune system, with the ultimate goal of being able to study these biological pathways and perhaps develop therapies for inflammatory diseases,” Chang said.
Inflammation is caused by the immune system as one of the body’s responses to eliminate infectious pathogens and other foreign or dangerous agents. When inflammation becomes chronic, it can lead to a host of diseases, including asthma, multiple sclerosis, rheumatoid arthritis, colitis and Crohn’s disease.
The researchers created a chemical probe that inhibits a reaction mediated by enzymes called histone deacetylases (HDACs). These enzymes regulate genes that turn on when the immune system is challenged and promote inflammation. HDACs also have inhibitors that suppress this inflammatory response, and the probe specifically activates these inhibitors but only in the presence of UV light. This is especially useful since HDACs are ubiquitous and have other biological effects, and most drugs affect the entire system, leading to unintended consequences.
“If you turned off all the HDACs in the body, you would probably be hitting a lot of pathways that you didn’t want to turn off,” said Chang. “We can control when and where we turn off the HDACs using light. The idea is that you can actually target the tissue that has chronic inflammation and regulate it by selectively inhibiting HDACs in the tissue that’s affected.”
Photodynamic therapies are being developed and have existing infrastructure in the clinic for the potential use of the new tool to inhibit inflammation in patients with inflammatory diseases, Chang said.
Learn more: New tool uses UV light to control inflammation
[osd_subscribe categories=’inflammation-2′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “INFLAMMATION”‘]
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation control
[google_news title=”” keyword=”inflammation control” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on:Inflammation control
- Master regulator of inflammation found — and it's in the brain stemon May 10, 2024 at 9:25 am
Research in mice suggests that specific neurons within the brain stem act like the dial on a thermostat — fine-tuning inflammation as and when required.
- Man contracts flesh-eating bacteria infection from walking barefoot on beachon May 10, 2024 at 7:45 am
A man has been left unable to walk after contracting a deadly flesh-eating bacterial infection after strolling barefoot across a beach. Brent Norman, from Charleston, South Carolina, is an avid ...
- Joe Burrow will deal with “on and off inflammation” for “quite some time,” says orthopedic surgeonon May 10, 2024 at 4:00 am
Dr. Kutsikovich explained that while orthopedic surgeries usually have a success rate of 90-95%, Burrow’s surgery, a scapholunate ligament repair surgery, only has a success rate of 75-80%.
- Infection Control and Biosafety Products Market Size, Share and Growth Opportunitieson May 7, 2024 at 5:00 pm
The current market research report delves into the demand dynamics of the Infection Control and Biosafety Products industry across various segments, offering insights into its size, share, growth ...
- Expert says three spices in your kitchen can control diabetes, inflammation and arthritison May 7, 2024 at 5:33 am
Health expert Kanchan Koya says these medicines are hiding in your spice rack and could help with diabetes and inflammation ...
- Intermittent fasting protects against liver inflammation and liver canceron May 6, 2024 at 4:59 pm
After a further four months of 5:2 intermittent fasting (on the same diet), these animals were compared with the non-fasting control group. The fasting mice had better blood values, less fatty liver ...
- APIC: How infection preventionists can build their careerson May 6, 2024 at 11:59 am
About 40% of infection preventionists are nearing retirement age, APIC said in a May 3 news release, highlighting the need for workers to broaden their leadership skills. The guide details how to ...
- Columbia researchers uncover brain's ability to control inflammationon May 2, 2024 at 9:36 am
This new discovery could provide an exciting therapeutic venue to control inflammation and immunity." Charles S. Zuker, PhD, study's senior author, a principal investigator at Columbia's Zuckerman ...
- Infection Controlon May 2, 2024 at 8:27 am
The person with the longest consecutive COVID-19 infection was a 72-year-old man in Amsterdam who was documented to have the infection for 612 days, Scientific American reported May 1.
via Bing News